Anti-aging research has progressed rapidly over the last several years, with Google and even Amazon billionaire Jeff Bezos buying in. But the field’s latest investments will come from Apollo Health Ventures, which has raised $180 million to fund early entrants in the burgeoning race to prolong human life, Endpoints News reports.
Apollo closed its second fund on Wednesday, about three years after closing its first fund at somewhere north of $20 million (though that figure could still go up if investors contribute to follow-on rounds). Read more.
